Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 צפיות
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
להראות יותר
תגובות בפייסבוק
לא נמצאו הערות